Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (561-570 of 4,097) with videos related to

Pageof 410
Sort By:
Cancer Cell|August 16, 2005
Metastasis gets site specificChristine E Horak, Patricia S Steeg
Cancer Cell|July 29, 2006
BRIT1 regulates early DNA damage response, chromosomal integrity, and cancerRekha Rai, Hui Dai, Asha S Multani, et al.
Cancer Cell|May 30, 2006
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapiesHongbin Ji, Danan Li, Liang Chen, et al.
Cancer Cell|March 7, 2025
Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung AdenocarcinomaLindsay M LaFave, Vinay K Kartha, Sai Ma, et al.
Cancer Cell|December 13, 2005
Kit-activating mutations cooperate with Spi-1/PU.1 overexpression to promote tumorigenic progression during erythroleukemia in miceOlivier Kosmider, Nicole Denis, Catherine Lacout, et al.
Cancer Cell|December 13, 2005
Decatenation checkpoint deficiency in stem and progenitor cellsMarc Damelin, Yi E Sun, Veronika Brundula Sodja, et al.
Cancer Cell|November 3, 2009
Mst out and HCC inBin Zhao, Qunying Lei, Kun-Liang Guan
Cancer Cell|November 3, 2009
Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylaseQing Zhang, Jinming Gu, Lianjie Li, et al.
Cancer Cell|November 16, 2005
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET proteinPaolo Neviani, Ramasamy Santhanam, Rossana Trotta, et al.
Cancer Cell|June 13, 2025
Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancerBenoit Rousseau, Mitesh Patel, Oliver Artz, et al.
Pageof 410

Showing results (561-570 of 4,097) with videos related to

Sort By:
Pageof 410
Cancer Cell|August 16, 2005
Metastasis gets site specificChristine E Horak, Patricia S Steeg
Cancer Cell|July 29, 2006
BRIT1 regulates early DNA damage response, chromosomal integrity, and cancerRekha Rai, Hui Dai, Asha S Multani, et al.
Cancer Cell|May 30, 2006
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapiesHongbin Ji, Danan Li, Liang Chen, et al.
Cancer Cell|March 7, 2025
Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung AdenocarcinomaLindsay M LaFave, Vinay K Kartha, Sai Ma, et al.
Cancer Cell|December 13, 2005
Kit-activating mutations cooperate with Spi-1/PU.1 overexpression to promote tumorigenic progression during erythroleukemia in miceOlivier Kosmider, Nicole Denis, Catherine Lacout, et al.
Cancer Cell|December 13, 2005
Decatenation checkpoint deficiency in stem and progenitor cellsMarc Damelin, Yi E Sun, Veronika Brundula Sodja, et al.
Cancer Cell|November 3, 2009
Mst out and HCC inBin Zhao, Qunying Lei, Kun-Liang Guan
Cancer Cell|November 3, 2009
Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylaseQing Zhang, Jinming Gu, Lianjie Li, et al.
Cancer Cell|November 16, 2005
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET proteinPaolo Neviani, Ramasamy Santhanam, Rossana Trotta, et al.
Cancer Cell|June 13, 2025
Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancerBenoit Rousseau, Mitesh Patel, Oliver Artz, et al.
Pageof 410